| Literature DB >> 25880996 |
Yared Assefa1, Feleke Moges2, Mengistu Endris3, Banchamlak Zereay4, Bemnet Amare5, Damtew Bekele6, Solomon Tesfaye7, Andargachew Mulu8,9, Yeshambel Belyhun10,11.
Abstract
BACKGROUND: Bacterial pathogens isolated from dacryocystitis patients are diverse and complex in terms of their distribution, prevalence, and antimicrobial susceptibility pattern. The clinical importance of microbial causes of dacryocystitis and pattern of drug resistance has not been reported in northwest Ethiopia. Moreover, the management of dacryocystitis is based on only clinical observation Therefore, this study attempted to identify and define clinical and microbiological characteristics of microbial agents of dacryocystitis and its antibiotic susceptibility patterns.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25880996 PMCID: PMC4396718 DOI: 10.1186/s12886-015-0016-0
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Distribution of patients investigated for dacryocystitis by sex and age group at University of Gondar Eye Specialized Hospital, Northwest Ethiopia, Gondar, Ethiopia from 2011 to 2012
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
| ||
|
|
| ||||
|
| 7.28 | 0.51 | |||
| ≤15 | 4 (30.8) | 9(69.2) | 13(100) | ||
| 16-30 | 1(20.0) | 4(80.0) | 3(100) | ||
| 31-45 | 4(28.6) | 10(71.4) | 14(100) | ||
| 46-60 | 3(42.9) | 4(57.1) | 7(100) | ||
| >61 | 7 (58.3) | 5(41.7) | 12(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 6.85 | 0.74 | |||
| Gondar city & its vicinity | 7(41.2) | 10(58.8) | 17(100) | ||
| Dembia-Alefa & Chilga-Metema route | 2(66.7) | 1(33.3) | 3(100) | ||
| Tikildingay-Dansha-Humera route | 1(25.06) | 3(75.0) | 4(100) | ||
| Wegera-Dabat-Debark route | 5(31.2) | 11(68.8) | 16(100) | ||
| D/Tabor town & its vicinity | 4 (50.0) | 4(50.0) | 8(100) | ||
| Maksegnit-Belesa route | 0(0.0) | 3 (100.0) | 3(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 4.82 | 0.09 | |||
| Agricultural based | 19(43.2) | 25(56.8) | 44(100) | ||
| Non-agricultural based | 0(0.0) | 7(100) | 7(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 0.22 | 0.90 | |||
| Yes | 1(50.0) | 1(50.0) | 2(100) | ||
| No | 18(36.7) | 31(63.3) | 49(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 1.44 | 0.49 | |||
| Yes | 8(44.4) | 10(55.6) | 18(100) | ||
| No | 11(33.3) | 22(66.7) | 33(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 12.57 | 0.05 | |||
| Weeks | 4(66.7) | 2(33.3) | 6(100) | ||
| Months | 5(62.50) | 3(37.5) | 8(100) | ||
| Years | 7(43.8) | 9(56.2) | 16(100) | ||
| I don’t know | 3(14.3) | 18(85.7) | 21(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 4.86 | 0.09 | |||
| Yes | 4 (80.0) | 1(20.0) | 5(100) | ||
| No | 15(32.7) | 31(67.4) | 46(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
|
| 0.89 | 0.58 | |||
| Acute | 5 (35.7) | 9(64.3) | 14(100) | ||
| Chronic | 14 (37.8) | 23(62.2) | 37(100) | ||
| Total | 19(37.3) | 32(62.7) | 51(100) | ||
Distribution of bacterial agents isolated from dacryocysitis infection among sex at University of Gondar Eye Specialized Hospital, Northwest Ethiopia, Gondar, Ethiopia from 2011 to 2012
|
| |||
|---|---|---|---|
|
|
| ||
|
|
|
| |
|
| |||
|
| 1 (16.7) | 5(83.3) | 6(11.8) |
| CNS* | 4 (44.4) | 5(55.6) | 9(17.6) |
|
| 0 (0.0) | 2(100.0) | 2(3.9) |
|
| 0 (0.0) | 2(100.0) | 2(3.9) |
|
| |||
|
| 0 (0.0) | 1(100.0) | 1(2.0) |
|
| 1(50.0) | 1(50.0) | 2(3.9) |
|
| 0 (0.0) | 3(100.0) | 3(5.9) |
|
| 0 (0.0) | 1(100) | 1(2.0) |
|
| 2(100.0) | 0(0.0) | 2(3.9) |
|
| 0 (0.0) | 1(100) | 1(2.0) |
|
| 0 (0.0) | 1(100) | 1(2.0) |
|
| 1(100.0) | 0 (0.0) | 1(2.0) |
|
| 9(29.0) | 22(71.0) | 31(60.8)** |
*CNS-Coagulase Negative Staphylococci.
**Among the total of 51 dacryocystitis cases.
Antimicrobial susceptibility test patterns of bacterial pathogens isolated from dacryocystitis infection, University of Gondar Eye Specialized Hospital, Northwest Ethiopia, Gondar, Ethiopia from 2011 to 2012
|
|
|
|
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
| 6(19.4) | S | 5(83.3) | 5(83.3) | 6(100.0) | - | 5(83.3) | 6(100.0) | 6(100.0) | 4(66.7) | 4(66.7) | 3(50.0) | 4(66.7) | 6(100.0) |
| R | 1(16.7) | 1(16.7) | 0(0.0) | - | 1(16.7) | 0(0.0) | 0(0.0) | 2(33.3) | 2(33.3) | 3(50.0) | 2(33.3) | 0(0.0) | ||
| CNS | 9(29.0) | S | 9(100.0) | 7(77.8) | 5(55.6) | - | 9(100.0) | 9(100.0) | 7(77.8) | 9(100) | 6(66.7) | 7(77.8) | 6(66.7) | 8(88.9) |
| R | 0(0.0) | 2(22.2) | 4(44.4) | - | 0(0.0) | 0(0.0) | 2(22.2) | 0(0.0) | 3(33.3) | 2(22.2) | 3(33.3) | 1(11.1) | ||
|
| 2(6.5) | S | 0(0.0) | 2(100.0) | 1(50.0) | - | 2(100.0) | 2(100.0) | 1(50.0) | 2(100) | 2(100) | 0(0.0) | 2(100) | 2(100) |
| R | 2(100.0) | 0(0.0) | 1(50.0) | - | 0(0.0) | 0(0.0) | 1(50.0) | 0(0.0) | 0(0.0) | 2(100.0) | 0(0.0) | 0(0.0) | ||
|
| 2(6.5) | S | 2(100.0) | 1(50.0) | 1(50.0) | - | - | 0(0.0) | 1(50.0) | 1(50.0) | 1(50.0) | 2(100.) | 0(0.0) | 2(100) |
| R | 0(0.0) | 1(50.0) | 1(50.0) | - | - | 2(100.0) | 1(50.0) | 1(50.0) | 1(50.0) | 0(0.0) | 2(100) | 0(0.0) | ||
|
| 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 0(0.0) | 1(100.0) | - | - | 0(0.0) | 1(100) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 0(0.0) | - | 1(100.0) | 0(0.0) | - | - | 1(100.0) | 0(0.0) | 0(0.0) | ||
|
| 2(6.5) | S | 1(50.0) | 1(50.0) | 2(100.0) | 2(100.0) | - | 1(50.0) | 2(100.0) | - | - | 1(50.0) | 2(100.) | 1(50.0) |
| R | 1(50.0) | 1(50.0) | 0(0.0) | 0(0.0) | - | 1(50.0) | 0(0.0) | - | - | 1(50.0) | 0(0.0) | 1(50.0) | ||
|
| 3(9.7) | S | 2(66.7) | 1(33.3) | 2(66.7) | 2(66.7) | - | 2(66.7) | 2(66.7) | - | - | 2(66.7) | 2(66.7) | 3(100.) |
| R | 1(33.3) | 2(66.7) | 1(33.3) | 1(33.3) | - | 1(33.3) | 1(33.3) | - | - | 1(33.3) | 1(33.3) | 0(0.0) | ||
|
| 1(3.2) | S | 1(100.0) | 1(100.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 1(100.0) | - | - | 1(100) | 1(100) | 1(100) |
| R | 0(0.0) | 0(0.0) | 0(0.0) | 0(0.0) | - | 0(0.0) | 0(0.0) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
|
| 2(6.5) | S | 2(100.0) | 0(0.0) | 2(100.0) | 2(100.0) | - | 2(100.0) | 1(50.0) | - | - | 1(50.0) | 1(50.0) | 2(100.0) |
| R | 0(0.0) | 2(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 1(50.0) | - | - | 1(50.0) | 1(50.0) | 0(0.0) | ||
|
| 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 1(100.0) | - | - | 1(100) | 1(100) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 0(0.0) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
|
| 1(3.2) | S | 0(0.0) | 0(0.0) | 1(100.0) | 1(100.0) | - | 1(100.0) | 0(0.0) | - | - | 1(100.0) | 1(100) | 1(100) |
| R | 1(100) | 1(100) | 0(0.0) | 0(0.0) | - | 0(0.0) | 1(100) | - | - | 0(0.0) | 0(0.0) | 0(0.0) | ||
|
| 1(3.2) | S | 1(100.0) | 0(0.0) | 1(100.0) | 0(0.0) | - | 1(100.0) | 1(100.0) | - | - | 0(0.0) | 0(0.0) | 1(100) |
| R | 0(0.0) | 1(100) | 0(0.0) | 1(100) | - | 0(0.0) | 0(0.0) | - | - | 1(100) | 1(100) | 0(0.0) | ||
|
| 31(100) | S | 25(80.6) | 19(61.3) | 23(74.2) | 10(83.3) | 17(89.5) | 27(87.1) | 23(74.2) | 16(84.2) | 13(68.4) | 22(71.0) | 23(74.2) | 29(93.5) |
| R | 6(19.4) | 12(38.7) | 8(25.8) | 2(16.7) | 2(10.5) | 4(12.9) | 8(25.8) | 3(15.8) | 6(31.6) | 6(29.0) | 8(25.8) | 2(6.5) | ||
Keys: AMP- Ampicillin, AMOX-Amoxicillin, CIP- Ciprofloxacin, CN- Gentamycin, MET- Methicillin, NA-Nalidic Acid, CAF-Chloramphinicol, ERY- Erythromycin, VAN- Vancomycin, PEN-penicillin, TTC- Tetracycline, SXT- Co-trimoxazole, CEF-Ceftriaxone. *Percentage calculation is based on column total [19] denominator.
Multiple antibiotic resistance patterns of bacterial pathogens isolated from dacryocystitis infection, University of Gondar Eye Specialized Hospital, Northwest Ethiopia, Gondar, Ethiopia from 2011 to 2012
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| ||
|
| 6(19.4) | 1(16.7) | 3(50.0) | 1(16.7) | - | - | 1(16.7) |
| CNS | 9(29.0) | 1 (11.1) | 4(44.4) | 1(11.1) | 1(11.1) | - | 2(22.2) |
|
| 2(6.5) | - | - | 1(50.0) | 1(50.0) | - | |
|
| 2(6.5) | - | - | - | 1(50.0) | 1(50.0) | |
|
| 1(3.2) | - | - | - | 1(100.0) | - | - |
|
| 2(6.5) | - | - | 1(50.0) | 1(50.0) | - | - |
|
| 3(9.7) | - | 1(33.3) | - | - | 2(66.7) | - |
|
| 1(3.2) | 1(100.0) | - | - | - | - | - |
|
| 2(6.5) | - | - | 1(50.0) | 1(50.0) | - | - |
|
| 1(3.2) | - | 1(100.0) | - | - | - | - |
|
| 1(3.2) | - | - | - | 1(100.0) | - | - |
|
| 1(3.2) | - | - | - | 1(100.0) | - | |
|
| 31(100) | 3 (9.7) | 9 (29.0) | 5(16.1) | 5(16.1) | 5(16.1) | 4 (12.9) |
Keys: Ro- sensitive to all antibiotics, R1 – resistant to 1 antibiotic.
R2- resistant to 2 antibiotics, R3 – resistant to 3 antibiotics.
R4- resistant to 4 antibiotics, R5 – resistant to 5 and more than 5 antibiotics.